Recognition sites for the excitatory neurotransmitter, L-glutamate, were studied in synaptic plasma membranes and postsynaptic densities (PSDs) isolated from rat brains. The results demonstrate (i) that L-glutamate binding sites may be resolved into three distinct subtypes (categories Al, A2, and A4), each corresponding to an electrophysiologically identified receptor class, and (it) that the N-methyl aspartate (Al) ), which is the major population present in SPMs, is absent from the PSD. Those sites present in PSDs may be subdivided into two populations which, as in the case of the electrophysiologically derived receptor classification scheme, are differentially sensitive to N-methyl DL-aspartate (NMeAsp) and quisqualate (sites Al and A2, respectively).MATERIALS AND METHODS Chemicals. L-[G-3H]Glutamic acid of specific radioactivity of 29-45 Ci/mmol (1 Ci = 37 GBq) was purchased from Amersham. Triton X-100 (gas chromatographic grade) and the L and D isomers of glutamic and aspartic acids were obtained from Merck; NMeAsp, quinolinic, and kainic acids, from Sigma; quisqualic, ibotenic, DL-2-amino-5-phosphonovaleric (DL-APV), and DL-2-amino-7-phosphonoheptanoic (DL-APH) acids, from Cambridge Research Biochemicals (Harston, U.K.); and DL-2-amino-3-phosphonopropionic acid and DL-APB, from Calbiochem (La Jolla, CA). DL-2-amino-6-phosphonohexanoic acid was kindly provided by J. F. Collins (London). Subcellular Fractionation. SPMs and PSDs were isolated from fresh brains (excluding brainstem) of adult male rats (strain RAI, 180-250 g; Ciba-Geigy). The SPM fraction was prepared by the method of Jones and Matus (19), and this was treated with either 0.5% or 1.0% Triton X-100, followed by centrifugation through 1.0 M sucrose, to yield PSDs (18,20) (the results obtained with either concentration of Triton X-100 were indistinguishable and were pooled). Fractions were washed four times by resuspension and cenAbbreviations: PSD, postsynaptic density; SPM, synaptic plasma membrane; APB, 2-amino-4-phosphonobutyrate; APH, 2-amino-7-phosphonoheptanoate; APV, 2-amino-5-phosphonovalerate; NMeAsp, N-methyl DL-aspartate; NMeDAsp, N-methyl D-aspartate.
6876The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "adiertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.